Consistently, the HOXB5 gene expression levels in AML patients with NPM1, FLT3, or DNMT3A mutations were higher than those in AML patients without gene mutations (Figure 2B and Supplementary Figure 4B). Here, NPM1 is linked to acute myeloid leukemia.